Loading...
Some studies have suggested that sickle cell trait (SCT) confers mildly elevated risk for various clinical conditions. However, biases in assembling SCT cohorts, inaccurate coding of diagnoses, and confounding by demographic factors are sources of ongoing uncertainty.
One unambiguous outcome is death. To examine mortality among people with SCT, researchers analyzed data from 470,000 general population participants (ages 40–70) in the U.K. Biobank; all underwent genetic testing at enrollment, and 1253 had SCT.
In analyses adjusted for numerous clinical and demographic variables, mortality during median follow-up of 15 years was not higher in people with SCT compared to those without it.
Those with SCT had statistically signif…